Clinical Trial Update: Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for bacteriophage therapy targeting chronic pulmonary infection caused by Mycobacterium abscessus; the study is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Infection

Drugs mentioned

• Bacteriophage therapy

Snippet

Sponsor: Alberta Health services | Conditions: Mycobacterium Abscessus Infection, Bacteriophage Therapy | Phase 1 | Status: NOT_YET_RECRUITING